| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |